This trial is looking at a new treatment for superficial bladder cancer called microwave induced hyperthermia use with local chemotherapy.  This will be compared to the standard treatments that are currently available for these patients.

Patient recruitment is now open.  Around 242 Patients will be enrolled from 20 plus NHS centres across the UK.

This trial is funded by Cancer Research UK, coordinated by the University of Birmingham CRUK- Clinical Trials Unit and sponsored by University College London.

If your NHS site is interested in participating in the HYMN trial please complete the feasibility questionnaire attached above and return to the HYMN trial office

For further information on the Synergo® hyperthermia device please go to the below website http://www.medical-enterprises.com/synergotech.html